LAMA4

Across TCGA pan-cancer cohorts, LAMA4 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LAMA4’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where LAMA4 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types LAMA4 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

CCRCC, COAD, and LUAD are the cancer types where LAMA4 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LAMA4 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	III,IV	+1.125	<.001	12	view →
COAD	Male	III,IV	−1.196	<.001	10	view →
LUAD	Female	II,III,IV	−1.140	<.001	9	view →
LSCC	Female	All	−0.878	<.001	8	view →
PDAC	Male	All	+0.376	<.001	6	view →
HNSC	All	All	−0.250	<.001	5	view →
OV	All	All	−1.231	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LAMA4–CCRCC

Open the CCRCC breakdown →